Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCSF
Dates
study started
completion around
Principal Investigator
by Erin Van Blarigan, ScD (ucsf)
Headshot of Erin Van Blarigan
Erin Van Blarigan

Description

Summary

This clinical trial evaluates whether an adaptive text-message intervention is useful in helping survivors of colorectal cancers (CRC) eat more whole grain foods and less refined grain foods. Most CRC survivors don't achieve the recommended intakes of whole grains or fiber, even though there is strong evidence that a high-fiber diet rich in whole grains lowers the risk of death from CRC. Dietary interventions are a promising approach for reducing death from CRC, and text message interventions specifically are a promising tool for reaching diverse populations. This trial evaluates a text-message based dietary intervention that continuously adapts message content to be specifically tailored for the participant for increasing whole grain consumption.

Official Title

Use of Text Messages to Increase Whole Grain Consumption in Colorectal Cancer

Details

PRIMARY OBJECTIVE:

  1. Determine the intervention's feasibility and acceptability.

SECONDARY OBJECTIVES:

  1. Estimate the effect of the intervention on the percent of grains consumed that are whole.

II. Estimate the effect of the intervention on total fiber intake (grams per day [g/d]).

EXPLORATORY OBJECTIVE:

  1. Assess convergence of the reinforcement learning (RL) algorithm.

OUTLINE:

Patients receive nutrition education materials and then receive the adaptive text message intervention for 12 weeks on study. Patients who are food insecure also receive resources for food banks, information about meal delivery programs, and support for applying for Supplemental Nutrition Assistance Program (SNAP) benefits.

Keywords

Colon Adenocarcinoma, Colorectal Carcinoma, Rectal Adenocarcinoma, Adenocarcinoma, Colorectal Neoplasms, Colonic Neoplasms, Dietary intervention via Text Messaging, Nutrition Education

Eligibility

You can join if…

Open to people ages 18 years and up

  1. Age > 18 years.
  2. Subject has provided informed consent.
  3. Diagnosis of colon or rectal adenocarcinoma.
  4. Not on active treatment at the time of screening and not expected to receive active anticancer therapy (e.g., surgery, radiation, chemotherapy) during the study period.
  5. At least 6 weeks since a major surgery and fully recovered.
  6. Owns a mobile phone and is willing and able to receive and send text messages.
  7. Able to speak/read English or Spanish.
  8. Based on a screening survey, eat grains and =<50% of total grains are whole grains.

You CAN'T join if...

  1. Does not meet any of the above inclusion criteria.

Locations

  • Zuckerberg San Francisco General accepting new patients
    San Francisco California 94110 United States
  • University of California, San Francisco accepting new patients
    San Francisco California 94143 United States

Lead Scientist at University of California Health

  • Erin Van Blarigan, ScD (ucsf)
    Associate Professor, Epidemiology & Biostatistics, School of Medicine. Authored (or co-authored) 35 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT05746195
Study Type
Interventional
Participants
Expecting 60 study participants
Last Updated